JOURNAL BROWSE
Search
Advanced SearchSearch Tips
DENTAL TREATMENT USING TRIAZOLAM FOR THE MENTAL RETARDATION PATIENT : A CASE REPORT
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
DENTAL TREATMENT USING TRIAZOLAM FOR THE MENTAL RETARDATION PATIENT : A CASE REPORT
Lee, Soo Jeong; Baek, Kwangwoo;
  PDF(new window)
 Abstract
Mental retardation is one of the major disorders covered in special care dentistry. Patients show poor oral health and are a challenge for the dentist due to lack of cooperation. Triazolam is a short-acting benzodiazepine and has been used in the dental office for many years because of its favorable properties. In this study, five patients with mental retardation were sedated with triazolam on a dental out-patient setting. Patients were administrated with 0.25 mg or 0.5 mg of triazolam on the first dose according to the patient`s cooperation. Twenty minutes after the initial dose, patients received 0.25 mg of triazolam. Triazolam was administrated sublingually to one patient and orally to four patients. Hydroxyzine was also administrated to three patients in order to prevent nausea and vomiting. All patients were inhaled with 50% nitrous oxide during the sedation. Treatment time ranged from 20 minutes to 55 minutes. Two patients showed paradoxical reactions and were administrated with intramuscular injections of flumazenil. In result, depending on the range of dental treatment and level of intellectual disability, we can assume that triazolam may be beneficial for sedation in disabled patients.
 Keywords
Triazolam;Mental retardation;Sedation;
 Language
Korean
 Cited by
 References
1.
http://www.index.go.kr/potal/main/EachDtlPageDetail.do?idx_cd=2768

2.
Chang JH : Dental treatments or patients with severe mental challenges. KDA, 49:739-748, 2011.

3.
Kim YJ : Dental considerations for special care dentistry according to the types of disabilities, KDA, 49:732-738, 2011.

4.
Kim SO : A survey of non-emergency and emergency deep sedation using sevoflurane inhalation for pediatric or disabled patients, J of Korean Acad Pediatr Dent, 41:18-26, 2014. crossref(new window)

5.
Faulks D, Hennequin M, Onody P, et al. : Sedation with 50% nitrous oxide/oxygen for outpatient dental treatment in individuals with intellectual disability. Dev Med Child Neurol, 49:621-625, 2007. crossref(new window)

6.
Yuzkat N, Cegin MB : Anesthesia Management of Patients with Mental Retardation. Medical science and discovery, 2:239-243, 2015.

7.
Ban MH, Chung SS : The Analysis of Outpatient Anesthesia for Dental Treatment in Handicapped Patients with Behavior Disorder. JKDSA, 14:57- 62, 2014.

8.
Cha MJ, Seo KS, Kim MS, Kim HJ : Analysis of Complications of Ambulatory General Anesthesia after Discharge in Patients Who are Taking Anticonvulsant. JKDSA, 14:95-100, 2014.

9.
Kong EK, Jung YJ, Baek KW : Dental Treatment for a Patient with Seizure History and Intellectual Disability under General Anesthesia: A Case Report. J Dent Anesth Pain Med, 8:35-39, 2008.

10.
Sostmann HJ, Crevoisier C, Bircher J : Dose equivalence of midazolam and triazolam. A psychometric study based on flicker sensitivity, reaction time and digit symbol substitution test. Eur J Clin Pharmacol, 36:181-187, 1989. crossref(new window)

11.
Raadal M, Coldwell SE, Karl HW, et al. : A randomized clinical trial of triazolam in 3- to 5-yearolds. J Dent Res, 78:1197-203, 1999. crossref(new window)

12.
Dionne R, Yagiela J, Donaldson M, et al. : Balancing efficacy and safety in the use of oral sedation in dental out-patients. J Am Dent Assoc, 137:502-513, 2006. crossref(new window)

13.
Kaufman E, Hargreaves KM, Dionne RA : Comparison of oral triazolam and nitrous oxide with placebo and intravenous diazepam for outpatient premedication. Oral Surg Oral Med Oral Pathol, 75:156-64, 1993. crossref(new window)

14.
Donaldson M, Gizzarelli G, Chanpong B : Oral sedation: a primer on anxiolysis for the adult patient, Anesth Prog, 54:118-28, 2007. crossref(new window)

15.
Berthold CW, Dionne RA, Corey SE : Comparison of sublingually and orally administered triazolam for premedication before surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 84:119-124, 1997. crossref(new window)

16.
Malamed SF : Sedation: A guide to patient management, 5th ed. St Louis, Mosby. 2010, pp 52-54, pp 97-4421.

17.
Scavone JM, Greenblatt DJ, Friedman H, Shader RI : Enhanced bioavailability of triazolam following sublingual versus oral administration. J Clin Pharmacol, 26:208-210, 1986. crossref(new window)

18.
Goodchild JH, Donaldson M : Calculating and justifying total anxiolytic doses of medications for in-office use. General dentistry, 54:545-7, 2006.

19.
Jackson DL, Milgrom P, Heacox GA, Kharasch ED : Pharmacokinetics and clinical effects of multidose sublingual triazolam in healthy volunteers. J Clin Psychopharmacol, 26:4-8, 2006. crossref(new window)

20.
Coldwell SE, Awamura K, Karl HW, et al. : Side effects of triazolam in children. Pediatr Dent, 21:18-25, 1999.